Gastroparesis is technically defined by a slow-emptying stomach, but here's the strange part: how fast someone's stomach actually empties often doesn't line up with how sick they feel. That disconnect isn't a minor footnote, it shapes how treatments get evaluated and why device-based options remain genuinely useful even when they don't fully "fix" the underlying test result.
Looking for treatment options for Gastroparesis?
Browse open Gastroparesis clinical trials near you! We'll handle the follow-up.
What's approved right now
Metoclopramide stimulates stomach contractions and has been the primary approved medicine since 1979, available as a pill, liquid, or injection, though long-term use carries a real risk of tardive dyskinesia. Metoclopramide nasal spray (Gimoti), approved in 2020, delivers the same drug through the nose instead of the gut, useful because a slow stomach can make oral absorption unpredictable in the first place.
Why patients improve even when the test says they shouldn't
Gastric electrical stimulation, an implanted device that sends mild electrical pulses to stomach muscle, has been used for years in gastroparesis that doesn't respond to medication. Multiple studies have found it meaningfully reduces nausea, vomiting, and other symptoms. But when researchers checked whether the stomach was actually emptying faster afterward, the results were often unrelated.
In one study, only 14 of 63 patients had their gastric emptying test normalize after a year on the device, and those whose test normalized didn't report better symptom relief than those whose test stayed abnormal. In other words, people were feeling better for reasons the emptying test alone doesn't capture, which is a genuinely open scientific question, not something doctors have fully explained yet.
What researchers are studying now
G-POEM (gastric peroral endoscopic myotomy) is a newer procedure that's easier on the body than surgery. Doctors use a thin tube called an endoscope to cut the muscle at the bottom of the stomach, helping it empty faster. No implant or surgery is needed.
The first G-POEM procedure was done in 2013. It's now used more often for patients who haven't gotten better with medication or with a gastric electrical stimulator. Researchers are currently comparing G-POEM directly against that older device-based treatment, and studying which patients benefit from it the most.
Other ongoing trials are testing relamorelin and similar drugs. These work differently than metoclopramide, using a different chemical pathway to help the stomach contract.
What keeps holding gastroparesis research back
The measurement problem. If gastric emptying speed and symptom severity don't reliably move together, as the Enterra data shows, researchers can't simply use a faster emptying test as proof a treatment is working. Many current trials now track both measures separately rather than assuming one predicts the other.
The refractory-patient problem. A meaningful share of patients don't respond well to medication at all, which is exactly the population most device and procedural research focuses on, but that also means these trials often recruit from a smaller, harder-to-reach patient pool than a typical medication trial would.
The overlap-with-other-conditions problem. Gastroparesis symptoms can look similar to other functional digestive disorders, and a formal diagnosis requires a specific abnormal test result, which means some people who might benefit from gastroparesis-focused research don't clearly qualify for it, and vice versa.
Does gastroparesis affect more than digestion?
Yes, often more than people expect. Nutritional deficiencies can develop if eating becomes difficult enough over time, and the unpredictability of symptoms can make planning meals, travel, or work genuinely stressful. If weight loss, dehydration, or the emotional toll of constant nausea is affecting you, that's worth raising directly with your gastroenterologist, since nutritional support options exist beyond just managing nausea itself.
Common myths, cleared up
"If a treatment doesn't speed up stomach emptying, it isn't working."
As the Enterra data shows, symptom improvement and faster emptying don't always move together, so a treatment can genuinely help even without normalizing the test.
"Gastroparesis always means major, restrictive diet changes forever."
Dietary adjustments, like smaller, more frequent, lower-fat meals, help many people, but the degree of restriction needed varies a lot and often changes over time as symptoms fluctuate.
"G-POEM is just a newer version of gastric electrical stimulation."
They work completely differently, one is an implanted electrical device, the other is an endoscopic procedure that physically changes the stomach outlet, and current research is specifically comparing the two rather than treating one as a simple upgrade of the other.
How to find a gastroparesis study through our platform
You can browse current studies by whether you're looking at medication, a device, or an endoscopic procedure, since these categories involve very different time commitments and eligibility requirements. For example, a G-POEM trial currently recruiting in Indianapolis is open to adults referred for endoscopic treatment of gastroparesis, and a related study is using body surface gastric mapping to measure G-POEM outcomes, a non-invasive skin-patch test that tracks stomach activity without another endoscopy. Our gastroparesis clinical trials page always shows the current live count of recruiting studies. Applying takes about 5 minutes, and a coordinator follows up to confirm fit.
Common questions
What are the first signs of gastroparesis? Early signs are often mistaken for ordinary indigestion: feeling full after just a few bites, bloating, mild nausea, or discomfort in the upper abdomen after eating. As the condition progresses, symptoms can include vomiting undigested food hours after a meal, unintended weight loss, and blood sugar swings in people with diabetes.
How is gastroparesis actually diagnosed?The standard test is a gastric emptying scan, where you eat a meal containing a small amount of radioactive material and a scanner tracks how long it takes to leave your stomach. Doctors also rule out a physical blockage first, usually with an upper endoscopy or imaging, since gastroparesis is defined by slow emptying with no obstruction present.
Is gastroparesis reversible, or is it permanent? It depends on the cause. Gastroparesis triggered by a temporary factor, like a viral infection or certain medications, can sometimes improve or resolve. Diabetes-related and idiopathic (unexplained) cases tend to be chronic, though symptoms can often be managed well enough that people maintain a good quality of life.
What foods should I avoid with gastroparesis? High-fat and high-fiber foods are usually the hardest to tolerate, since both slow stomach emptying further. Many patients do better with smaller, more frequent meals and softer or well-cooked foods rather than raw vegetables or fibrous produce.
Is gastroparesis hereditary? Not directly, but some of its underlying causes can run in families. Diabetes, one of the most common causes, has a genetic component, so a family history of diabetes can indirectly raise gastroparesis risk. There's no single "gastroparesis gene" that's passed down on its own.